STAT3 and inflammatory bowel disease: In summary, we suggest that the protective role of gp130-dependent STAT3 activationin experimental IBD involves the expansion and activation of mucosal MDSCs thatexpress high levels of arginase 1 and anti-inflammatory Th2 cell cytokines (Fig. 9).